Betacyanins and their effects on cardiometabolic diseases.
| Source | Model: in vitro/in vivo | Dosage/Duration of treatment | Biological effects and mechanisms of action | References |
|---|---|---|---|---|
| Betacyanin (red beetroot, Beta vulgaris) | Human subjects | 3 days, 14 days114.5 mg/day betacyanins, 15.6 mg/day polyphenols, nitrate 228.5 mg/day | ↑ Akkermansia muciniphila, Escherichia coli↓ Bacteroides fragilisPositive correlations of betacyanins and Bifidobacterium and CoprococcusmInverse correlation of betacyanins with Ruminococcus and Peptoniphilus↑ SCFAs (butyric and isobutyric)Total excreted amount of betacyanins positively correlated with contents of (iso)butyric acid, (iso)valeric acid and total SCFAs; (iso)butyric acid and total SCFA contents showed a positive relationship with genera Blautia, Collinsella, Lachnobacterium, and Lactobacillus, but inverse association with Ruminococcus | Wang et al. [170], 2023 |
| Betanin (fresh beetroot juice, Beta vulgaris) | In vivoWistar rats, high-fat food | 20 mg/kg20 days | ↓ Blood glucose levels, insulin and insulin resistance↓ Liver damage (AST and ALT levels) and hepatic lipid accumulation↓ Oxidative stress [decreased hepatic MDA, increased superoxidase dismutase, catalase (CAT) and glutathione peroxidase (GPx) activities]↓ Plasma triglycerides | da Silva et al. [160], 2019 |
| Betanin (pure compound) | In vivoStreptozotocin-induced diabetic animalSprague-Dawley rats | 10, 20 and 40 mg/kg body weight28 days | ↓ Fasting blood glucose concentration↑ Serum insulin levelImproved glucose tolerance testImproved lipid profile and liver enzymes concentrationsImproved liver and pancreas histology↑ AMPK and SIRT1↓ NF-κB mRNA expressions | Abedimanesh et al. [163], 2021 |
| Betanin (pure compound) | In vivoStreptozotocin-induced diabetic animalSprague-Dawley rats | 10, 20 and 40 mg/kg body weight28 days | ↑ Total antioxidant capacity level, protein carbonyl and malondialdehyde (MDA)↑ Activity of hepatic antioxidant enzymes, superoxide dismutase (SOD), CAT, and GPx↑ Expression of Nrf2, SOD, GPx, and CAT genes | Mousavi et al. [161], 2022 |
| Betanin and neobetanin (red beetroot and yellow prickly pear) | In vitroRAW 264.7 macrophages | 10, 50, 100 μM | ↓ Inflammatory cytokines mRNA expressions (IL-6, IL-1β, iNOS, and COX-2)↓ ROS formation↓ NOX-2 mRNA levels↑ HO-1 and γGCS mRNA expression↑ IL-10 mRNA expression | Fernando et al. [165], 2023 |
| Hylocereus undatus peel (white pitaya) | In vivoC57BL/6 mice | 50, 100 and 200 mg/kg14 weeks | ↓ High-fat diet induced body weight gain↓ Adipose tissue hypertrophy↓ Hepatosteatosis, insulin resistanceImproved glucose tolerance↑ Expression of lipid metabolism related genes (AdipoR2, Cpt1a, Cpt1b, Acox1, PPARγ, Insig1, and Insig2)↑ Expression of FGF21-related genes (β-Klotho and FGFR1/2)Effects might be due to improved fatty acid oxidation, ↓ fatty acid biosynthesis, ↓ FGF21 resistance | Song et al. [8], 2016 |
| Hylocereus polyrhizus (red pitaya) | In vivoC57BL/6 mice | 200 mg/kg14 weeks | ↓ High-fat diet induced body weight gain↓ Visceral adipose tissue weight↓ Serum levels of blood lipids↓ Hepatic steatosis↓ Size of both white and brown adipocyte↓ Glucose intolerance and insulin resistance↓ Inflammatory cytokines (IL6, IL-1β, TNF-α) but ↑ anti-inflammatory cytokine (IL-10)↓ Firmicutes proportion↑ Bacteriodetes and Proteobacteria proportions | Song et al. [128], 2016 |
| Hylocereus polyrhizus cv. Jindu (betacyanin and anthocyanins) | In vitro3T3-L1 cells | 0.0625–1.0 mg/mL24 and 48 h | Both peel and pulp extract had similar total antioxidant activities against H2O2-induced oxidative stress on 3T3-L1 cell linePeel extract had inhibitory effects on 3T3-L1 cell lipid accumulation | Khoo et al. [27], 2022 |
| Betanin | In vitro3T3-L1 cells | 10–50 μM of betanin for 72 h (lipid accumulation)24 h for protein and 6 h for gene expressions | ↓ Number of lipid dropletsBetanin levels at 10, 25 and 50 μM ↓ lipid accumulation by 19.6%, 26.1% and 32.6%, respectivelyBetanin levels at 10, 25 and 50 μM ↓ intracellular triglyceride levels in 3T3-L1 adipocytes by 10.5%, 16.6% and 18.1%Suppressed expression of adipogenic genes PPARγ, C/EBPα and SREBP-1c↓ PPARγ protein expression | Chen et al. [169], 2019 |
| Hylocereus polyrhizus (betalains including betacyanins) | Human subjects (healthy men and women) | Double-blind, randomized controlled crossover trial24 g of dragon fruit powder containing 33 mg of betalains, 14 days | Both acute and sustained consumption of dragon fruit improved flow-mediated dilationAcute consumption ↓ pulse-wave velocity but not sustained consumption↓ Heart-rate augmentation index after 14 daysNo significant changes in blood pressure (central systolic and peripheral diastolic)Only two metabolites were significantly increased in the plasma after consumption of dragon fruit powder | Cheok et al. [167], 2022 |
| Opuntia elatior Mill (red flower prickly pear)Betanin | In vivoSprague-Dawley rats (STZ-induced) | 25, 50, and 100 mg/kg/day8 weeks | Inhibiting proteinuria↓ Blood glucose and nephrotoxicity markers (serum creatinine and BUN levels)Restored antioxidant enzymes activities in kidney tissues (↓ TBARS, ↑ SOD, CAT)↓ Glomerular surface area, glomerulosclerosis, tubulointerstitial fibrosisModulated mRNA and protein expression of TGF-β, type IV collagen, α-SMA and E-cadherin | Sutariya and Saraf [168], 2017 |
| Opuntia robustaBetacyanin/Betanin | In vivoWistar rats [diclofenac (DF)-induced acute liver injury model] | Opuntia robusta (OR) fruit extract (800 mg/kg/5 days, orally) (4.45 mg of betanin equivalents)Betanin (25 mg/kg/5 days, orally) | Pretreatment with OR extract and betanin ↓ MDA levels and maintained GSH levelOR extract increased Cat, Sod1 expressionBetanin ↑ Cat expressionOR extract or betanin only ↓ Sod2 expression but DF treatment ↑ Sod2 expression with corresponding treatmentsOR or betanin ↑ Nrf2 gene expressionOR or betanin ↓ Hmox1, Gclc expressionsOR or betanin ↓ active caspase-3-positive cells | Villa-Jaimes et al. [162], 2023 |
| Opuntia stricta (Prickly pear cactus)Betalain/Betacyanin | Human subjects (men with coronary artery disease)Randomised, double-blind, crossover trial: 2 weeks each (total duration 10 weeks) | 50 mg betacyanin/betalains per day (blood collection 12 h post fasting, 0, 14, 28, 42, 56 and 70 days) | ↓ Homocysteine level↓ Systolic blood pressure↓ Fasting blood glucose↓ Non-HDL cholesterol and LDL cholesterol | Rahimi et al. [166], 2019 |
↑: increase; ↓: decrease; CAT: catalase; COX-2: cyclooxygenase-2; iNOS: inducible nitric oxide synthase; NF-κB: nuclear factor-kappa B; Nrf2: nuclear factor erythroid 2-related factor 2; ROS: reactive oxygen species; SCFAs: short-chain fatty acids; SIRT1: Sirtuin-1; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BUN: blood urea nitrogen; C/EBPα: CCAAT/enhancer-binding protein alpha; FGF21: fibroblast growth factor 21; FGFR1/2: FGF receptor 1/2; GSH: reduced glutathione; HO-1: heme oxygenase 1; PPARγ: peroxisome proliferator-activated receptor gamma; SREBP-1c: sterol regulatory element-binding protein 1c; TGF-β: transforming growth factor beta; TNF-α: tumor necrosis factor alpha; α-SMA: alpha-smooth muscle actin.
The authors would like to thank Mr. James Wong Yung Khai and Mr. Luther Ku for their assistance in drawing some of the diagrams in this manuscript. English grammar was improved using the Grammarly application and proofread by Dr. Elvin M. Walemba.
ODJ: Supervision, Project administration, Conceptualization, Investigation, Visualization, Writing—original draft, Writing—review & editing. WGS: Investigation, Visualization, Writing—original draft. APGdS: Conceptualization, Investigation, Visualization, Writing—original draft, Writing—review & editing. SAT: Investigation, Writing—original draft, Writing—review & editing, Validation. CYB: Investigation, Writing—original draft, Writing—review & editing, Validation. RN: Investigation, Writing—original draft, Writing—review & editing, Validation. EMW: Investigation, Writing—original draft, Writing—review & editing, Validation. ATM: Conceptualization, Investigation, Visualization, Writing—original draft, Writing—review & editing, Validation. All authors have read and agreed to the published version of the manuscript.
The authors declare that there are no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2026.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.